May 19-24 American Thoracic Society International Conference, Washington D.C. A world leader in conducting pulmonary and respiratory disease research for more than 60 years, Lovelace Biomedical will be presenting at ATS 2017. The presentation is titled "Inhibition of Lung Fibrosis by INS1009, an Inhaled Prodrug Hexadecyl-Treprostinil Formulated in a Lipid Nanoparticle, Administered Therapeutically in Rats."